Viable osteogenic cells are obligatory for tissue-engineered ectopic bone formation in goats
- PMID: 12740095
- DOI: 10.1089/107632703764664792
Viable osteogenic cells are obligatory for tissue-engineered ectopic bone formation in goats
Abstract
In this study we investigated the bone-forming capacity of tissue-engineered (TE) constructs implanted ectopically in goats. As cell survival is questionable in large animal models, we investigated the significance of vitality, and thus whether living cells instead of only the potentially osteoinductive extracellular matrix are required to achieve bone formation. Vital TE constructs of porous hydroxyapatite (HA) covered with differentiated bone marrow stromal cells (BMSCs) within an extracellular matrix (ECM) were compared with identical constructs that were devitalized before implantation. The devitalized implants did contain the potentially osteoinductive ECM. Furthermore, we evaluated HA impregnated with fresh bone marrow and HA only. Two different types of HA granules with a volume of approximately 40 microm were investigated: HA70/800, a microporous HA with 70% interconnected macroporosity and an average pore size of 800 microm, and HA60/400, a smooth HA with 60% interconnected macropores and an average size of 400 microm. Two granules of each type were combined and then treated as a single unit for cell seeding, implantation, and histology. The tissue-engineered samples were obtained by seeding culture-expanded goat BMSCs on the HA and subsequently culturing these constructs for 6 days to allow cell differentiation and ECM formation. To devitalize, TE constructs were frozen in liquid nitrogen according to a validated protocol. Fresh bone marrow impregnation was performed perioperatively (4 mL per implant unit). All study groups were implanted in bilateral paraspinal muscles. Fluorochromes were administered at three time points to monitor bone mineralization. After 12 weeks the units were explanted and analyzed by histology of nondecalcified sections. Bone formation was present in all vital tissue-engineered implants. None of the other groups showed any bone formation. Histomorphometry indicated that microporous HA70/800 yielded more bone than did HA60/400. Within the newly formed bone, the fluorescent labels showed that mineralization had occurred before 5 weeks of implantation and was directed from the HA surface toward the center of the pores. In conclusion, tissue-engineered bone formation in goats can be achieved only with viable constructs of an appropriate scaffold and sufficient BMSCs.
Similar articles
-
Towards injectable cell-based tissue-engineered bone: the effect of different calcium phosphate microparticles and pre-culturing.Tissue Eng. 2006 Feb;12(2):309-17. doi: 10.1089/ten.2006.12.309. Tissue Eng. 2006. PMID: 16548689
-
Bone formation by mesenchymal progenitor cells cultured on dense and microporous hydroxyapatite particles.Tissue Eng. 2003 Dec;9(6):1179-88. doi: 10.1089/10763270360728080. Tissue Eng. 2003. PMID: 14670105
-
Novel hydroxyapatite/chitosan bilayered scaffold for osteochondral tissue-engineering applications: Scaffold design and its performance when seeded with goat bone marrow stromal cells.Biomaterials. 2006 Dec;27(36):6123-37. doi: 10.1016/j.biomaterials.2006.07.034. Epub 2006 Aug 30. Biomaterials. 2006. PMID: 16945410
-
Bone marrow stromal cells and their use in regenerating bone.Novartis Found Symp. 2003;249:133-43; discussion 143-7, 170-4, 239-41. Novartis Found Symp. 2003. PMID: 12708654 Review.
-
Mesenchymal stem cells and bioceramics: strategies to regenerate the skeleton.Novartis Found Symp. 2003;249:118-27; discussion 127-32, 170-4, 239-41. Novartis Found Symp. 2003. PMID: 12708653 Review.
Cited by
-
Vascularized bone tissue engineering: approaches for potential improvement.Tissue Eng Part B Rev. 2012 Oct;18(5):363-82. doi: 10.1089/ten.TEB.2012.0012. Epub 2012 Sep 4. Tissue Eng Part B Rev. 2012. PMID: 22765012 Free PMC article. Review.
-
A differential effect of bone morphogenetic protein-2 and vascular endothelial growth factor release timing on osteogenesis at ectopic and orthotopic sites in a large-animal model.Tissue Eng Part A. 2012 Oct;18(19-20):2052-62. doi: 10.1089/ten.TEA.2011.0560. Epub 2012 Sep 12. Tissue Eng Part A. 2012. PMID: 22563713 Free PMC article.
-
Clinical application of human mesenchymal stromal cells for bone tissue engineering.Stem Cells Int. 2010 Nov 11;2010:215625. doi: 10.4061/2010/215625. Stem Cells Int. 2010. PMID: 21113294 Free PMC article.
-
Sustained release of bone morphogenetic protein 2 via coacervate improves the osteogenic potential of muscle-derived stem cells.Stem Cells Transl Med. 2013 Sep;2(9):667-77. doi: 10.5966/sctm.2013-0027. Epub 2013 Jul 24. Stem Cells Transl Med. 2013. PMID: 23884640 Free PMC article.
-
Expansion and characterization of human embryonic stem cell-derived osteoblast-like cells.Cell Reprogram. 2010 Aug;12(4):377-89. doi: 10.1089/cell.2009.0079. Cell Reprogram. 2010. PMID: 20698777 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials